Medical Access International Inc is categorized under Health Services in East Longmeadow, MA and active since 2010.
Medical Access International Inc was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Valerie J Cowieson at the company’s single location by writing to 24 Crestview Road, East Longmeadow, Massachusetts MA 01028 or by phoning (413) 885-3416. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Medical Access International Inc |
Contact Person: | Valerie J Cowieson |
Address: | 24 Crestview Road, East Longmeadow, Massachusetts 01028 |
Phone Number: | (413) 885-3416 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Health Services |
SIC Code: | 8099 |
NAICS Code: | 621999 |
Share This Business: |
Medical Access International Inc was started in 2010 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Valerie J Cowieson for inquiries that concern Medical Access International Inc by calling the company number (413) 885-3416, as your correspondence is most welcome. Additionally, the physical location of the single location of Medical Access International Inc can be found at the coordinates 42.037537,-72.489143 as well as the street address 24 Crestview Road in East Longmeadow, Massachusetts 01028.
For its online presence, you may visit Medical Access International Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.